Consolidated Portfolio Review Corp’s PIMCO Corporate & Income Strategy Fund PCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-279,717
Closed -$3.74M 282
2025
Q3
$3.74M Buy
279,717
+33,289
+14% +$429K 0.47% 50
2025
Q2
$3.13M Buy
246,428
+122,248
+98% +$1.55M 0.43% 56
2025
Q1
$1.7M Sell
124,180
-9,540
-7% -$130K 0.27% 94
2024
Q4
$1.79M Buy
133,720
+1,488
+1% +$20.7K 0.28% 95
2024
Q3
$1.88M Buy
132,232
+2,545
+2% +$34.5K 0.42% 58
2024
Q2
$1.71M Buy
+129,687
New +$1.7M 0.4% 62

Other funds holding PCN

Consolidated Portfolio Review Corp's PCN Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of PIMCO Corporate & Income Strategy Fund (PCN) in Q4 2025, closing a stake of 279,717 shares — an estimated $3.74M sold.

Consolidated Portfolio Review Corp first reported a position in PCN in Q2 2024 and held it in 6 quarters. The position peaked at $3.74M in Q3 2025. 117 funds tracked by Wall St. Rank hold PCN as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining PIMCO Corporate & Income Strategy Fund position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 279,717 PIMCO Corporate & Income Strategy Fund shares in Q4 2025, an estimated $3.74M.
  • Consolidated Portfolio Review Corp first reported a position in PIMCO Corporate & Income Strategy Fund in Q2 2024 and held it in 6 quarters.
  • Consolidated Portfolio Review Corp's PIMCO Corporate & Income Strategy Fund position peaked at $3.74M in Q3 2025.
  • 117 funds tracked by Wall St. Rank held PIMCO Corporate & Income Strategy Fund as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.